Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Gross Margin (2010 - 2011)

Updated

Mosaic ImmunoEngineering (CPMV) posted Gross Margin of 74.13% for Q2 2012, up 75.66 percentage points from -1.53% a year earlier but down 1.29 percentage points from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Gross Margin (2010 - 2011) Analysis & Trends

For the trailing twelve months through Nov 30, 2011, Gross Margin at Mosaic ImmunoEngineering was 39.37%.

  • Quarterly Gross Margin has run from a low of -1.53% in Q2 2011 to a high of 75.41% in Q1 2012 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 Mosaic ImmunoEngineering 434,528.21 434,528.21 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 74.13%
Aug 31, 2011 75.41%
Nov 30, 2010 -1.53%
Aug 31, 2010 1.86%
API Access

Mosaic ImmunoEngineering Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CPMV&period=max&api_key=YOUR_API_KEY